COVID-19 Viewpoints
Filter by:
Congress Acts to Mitigate COVID-19 Impact
March 18, 2020 | Blog | By Anthony DeMaio, William Kannel
Below is an update on legislative efforts by Congress and the White House to address the coronavirus pandemic, prepared by our D.C. colleagues at ML Strategies, who are closely following these fluid and fast-moving developments. Efforts to provide a supply of low cost working capital to the many businesses and entities experiencing operational and/or cash flow disruption may be of particular interest to our bondholder clients.
Read more
Update from Washington – Coronavirus Response
March 17, 2020 | Advisory | By Alexander Hecht, Anthony DeMaio
In response to the coronavirus pandemic, Congress and President Trump have taken the following actions:
Read more
Federal Response to COVID-19
March 16, 2020 | Alert | By Alexander Hecht, Frank C. Guinta, Christian Tamotsu Fjeld, R. Neal Martin, Anthony DeMaio
Read about the federal government’s response to COVID-19, including $8B in emergency funding and the Families First Coronavirus Response Act pending in the House.
Read more
What the COVID-19 Pandemic Means for Force Majeure Provisions
March 13, 2020 | Alert | By Samuel M. Tony Starr, Kaitlyn C. Leonard , Clare Prober
Read about what the World Health Organization’s declaration that COVID-19 is a pandemic means for force majeure provisions in contracts.
Read more
In Response to COVID-19, IRS Provides High Deductible Health Plan Relief
March 12, 2020 | Blog | By Patricia Moran
On March 12, 2020, the IRS issued notice 2020-15, providing that a health plan will not fail to be a High Deductible Health Plan (HDHP) merely because it provides testing for and treatment of COVID-19 without a deductible or subject to a reduced deductible. Therefore, an individual who participates in such a plan may continue to participate in a Health Savings Account (HSA).
Read more
What You Need to Know about Force Majeure in Light of the Coronavirus
March 10, 2020 | Alert | By Samuel M. Tony Starr, Kaitlyn C. Leonard , Clare Prober
With the outbreak of coronavirus disease 2019 (“COVID-19”), the disease caused by the novel coronavirus (“SARS-CoV-2”), companies across various industries are taking precautions, some of which already have, and inevitably will result in nonperformance of their contracts.
Read more